JP2022514271A5 - - Google Patents
Info
- Publication number
- JP2022514271A5 JP2022514271A5 JP2021534702A JP2021534702A JP2022514271A5 JP 2022514271 A5 JP2022514271 A5 JP 2022514271A5 JP 2021534702 A JP2021534702 A JP 2021534702A JP 2021534702 A JP2021534702 A JP 2021534702A JP 2022514271 A5 JP2022514271 A5 JP 2022514271A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- raav
- nucleic acid
- composition according
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862781380P | 2018-12-18 | 2018-12-18 | |
| US62/781,380 | 2018-12-18 | ||
| PCT/US2019/067247 WO2020132115A1 (en) | 2018-12-18 | 2019-12-18 | Methods and compositions for treating glycogen storage diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514271A JP2022514271A (ja) | 2022-02-10 |
| JP2022514271A5 true JP2022514271A5 (OSRAM) | 2022-05-20 |
| JP7486274B2 JP7486274B2 (ja) | 2024-05-17 |
Family
ID=69400618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534702A Active JP7486274B2 (ja) | 2018-12-18 | 2019-12-18 | 糖原病を処置するための方法および組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220017922A1 (OSRAM) |
| EP (1) | EP3898981B1 (OSRAM) |
| JP (1) | JP7486274B2 (OSRAM) |
| CN (1) | CN113454226B (OSRAM) |
| AU (1) | AU2019405758B2 (OSRAM) |
| BR (1) | BR112021012104A2 (OSRAM) |
| CA (1) | CA3123841A1 (OSRAM) |
| DK (1) | DK3898981T5 (OSRAM) |
| ES (1) | ES2969222T3 (OSRAM) |
| IL (1) | IL283956A (OSRAM) |
| MX (1) | MX2021007379A (OSRAM) |
| PL (1) | PL3898981T3 (OSRAM) |
| PT (1) | PT3898981T (OSRAM) |
| WO (1) | WO2020132115A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023069891A1 (en) * | 2021-10-19 | 2023-04-27 | University Of Connecticut | Compositions and methods for the treatment of glycogen storage disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6759050B1 (en) | 1998-12-03 | 2004-07-06 | Avigen, Inc. | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| JP2002191363A (ja) * | 1999-07-29 | 2002-07-09 | Herikkusu Kenkyusho:Kk | 全長ｃＤＮＡ合成用プライマー、およびその用途 |
| US7261544B2 (en) | 2003-05-21 | 2007-08-28 | Genzyme Corporation | Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| CA2713338C (en) | 2008-01-29 | 2021-10-26 | Applied Genetic Technologies Corporation | Recombinant virus production using mammalian cells in suspension |
| US8679837B2 (en) | 2009-04-02 | 2014-03-25 | University Of Florida Research Foundation, Inc. | Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors |
| ES2680915T3 (es) | 2010-01-28 | 2018-09-11 | The Children's Hospital Of Philadelphia | Plataforma de fabricación escalable para la purificación de vectores virales y vectores virales purificados de este modo para su utilización en terapia génica |
| AU2014216160B2 (en) * | 2013-02-15 | 2017-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | AAV8 retinoschisin expression vector for treating X-linked retinoschisis |
| US9644216B2 (en) * | 2013-11-26 | 2017-05-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adeno-associated virus vectors for treatment of glycogen storage disease |
| ES2824829T3 (es) * | 2014-12-23 | 2021-05-13 | Us Health | Vectores de virus adenoasociado que codifican G6PC modificada y usos de estos |
| LT3436593T (lt) | 2016-03-28 | 2023-03-10 | Ultragenyx Pharmaceutical Inc. | Adenoviruso šiluminio inaktyvavimo būdai |
| JP2020506695A (ja) * | 2017-01-30 | 2020-03-05 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 糖原病を処置するための組換えウイルスベクター |
-
2019
- 2019-12-18 DK DK19845789.7T patent/DK3898981T5/da active
- 2019-12-18 AU AU2019405758A patent/AU2019405758B2/en active Active
- 2019-12-18 WO PCT/US2019/067247 patent/WO2020132115A1/en not_active Ceased
- 2019-12-18 ES ES19845789T patent/ES2969222T3/es active Active
- 2019-12-18 PL PL19845789.7T patent/PL3898981T3/pl unknown
- 2019-12-18 EP EP19845789.7A patent/EP3898981B1/en active Active
- 2019-12-18 US US17/311,869 patent/US20220017922A1/en active Pending
- 2019-12-18 CN CN201980083410.8A patent/CN113454226B/zh active Active
- 2019-12-18 BR BR112021012104-8A patent/BR112021012104A2/pt unknown
- 2019-12-18 MX MX2021007379A patent/MX2021007379A/es unknown
- 2019-12-18 PT PT198457897T patent/PT3898981T/pt unknown
- 2019-12-18 CA CA3123841A patent/CA3123841A1/en active Pending
- 2019-12-18 JP JP2021534702A patent/JP7486274B2/ja active Active
-
2021
- 2021-06-13 IL IL283956A patent/IL283956A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP7374119B2 (ja) | 減少した肝臓向性を有するＡＡＶ９とＡＡＶｒｈ７４とのハイブリッド組換えアデノ随伴ウイルス血清型 | |
| JP2022500066A5 (OSRAM) | ||
| ES2640586T3 (es) | Secuencias del factor VIII | |
| JP2021531752A5 (OSRAM) | ||
| JP2021533805A5 (OSRAM) | ||
| JP2024523707A5 (OSRAM) | ||
| TW201706412A (zh) | Ｆａｂｒｙ氏病基因療法 | |
| JP2022520232A5 (OSRAM) | ||
| KR20160033217A (ko) | 변종 ａａｖ 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도 | |
| JP2023515072A5 (OSRAM) | ||
| JP2023534037A5 (OSRAM) | ||
| JP7558535B2 (ja) | アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療 | |
| JP7702949B2 (ja) | ヒトｍｅｃｐ２遺伝子を発現するように設計されたトランスジーンカセット | |
| JP2019524090A5 (OSRAM) | ||
| JP2024545183A5 (OSRAM) | ||
| JP2022551739A5 (OSRAM) | ||
| JP2020054367A (ja) | 改変ｇ６ｐｃをコードするアデノ随伴ウイルスベクターおよびその使用 | |
| JP2022516317A5 (OSRAM) | ||
| FI3850089T3 (fi) | Polynukleotidejä | |
| JP2024546103A5 (OSRAM) | ||
| JP2024527742A5 (OSRAM) | ||
| JP2024119900A (ja) | 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法 | |
| WO2023202469A1 (zh) | 一种用于遗传性凝血因子缺乏病治疗的核酸构建体及其用途 | |
| JP2023535232A5 (OSRAM) |